Kennedy Capital Management’s Teladoc Health TDOC Stock Holding History

Kennedy Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,292	Closed	-$2.21M	–	714
2020 Q1	$2.21M	Sell	14,292 -12,290	-46%	-$1.43M	0.08%	434
2019 Q4	$2.23M	Sell	26,582 -3,803	-13%	-$289K	0.05%	526
2019 Q3	$2.06M	Sell	30,385 -2,093	-6%	-$138K	0.05%	523
2019 Q2	$2.16M	Buy	32,478 +852	+3%	+$49.7K	0.05%	530
2019 Q1	$1.76M	Sell	31,626 -29,788	-49%	-$1.82M	0.04%	555
2018 Q4	$3.04M	Buy	+61,414	New	+$3.76M	0.08%	458
2018 Q1	–	Sell	-138,853	Closed	-$4.84M	–	761
2017 Q4	$4.84M	Sell	138,853 -104,884	-43%	-$3.48M	0.09%	435
2017 Q3	$8.08M	Buy	+243,737	New	+$7.99M	0.15%	226

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Kennedy Capital Management's TDOC Position: Q2 2020 in Review

Kennedy Capital Management sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 14,292 shares — an estimated $2.21M sold.

Kennedy Capital Management first reported a position in TDOC in Q3 2017 and held it in 8 quarters. The position peaked at $8.08M in Q3 2017. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Kennedy Capital Management reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Kennedy Capital Management sold 14,292 Teladoc Health shares in Q2 2020, an estimated $2.21M.
Kennedy Capital Management first reported a position in Teladoc Health in Q3 2017 and held it in 8 quarters.
Kennedy Capital Management's Teladoc Health position peaked at $8.08M in Q3 2017.
670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Kennedy Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.